JPMorgan raises Alkem Laboratories target to ₹6,100
pre-market1 source ↓written by the desknot a recommendation
- target price
- ₹6,100
- ₹5,900
- from the current
- 13.6%
- market price
- ₹5,368
- US sales grew
- 6.5%
JPMorgan has maintained a Neutral rating on Alkem Laboratories while raising its target price to ₹6,100 from ₹5,900. This reflects an upside of 13.6% from the current market price of ₹5,368. US sales grew 6.5%, but non-US sales surged 35% year-on-year, indicating stronger international performance despite muted domestic growth.
Not investment advice. For informational purposes only.